physIQ licenses virtual trial tech to Janssen in multi-year dealBiosensor firm physIQ has licensed its technology to Johnson & Johnson’s Janssen pharma unit in a multi-year deal, Share XphysIQ licenses virtual trial tech to Janssen in multi-year dealhttps://pharmaphorum.com/news/physiq-licenses-virtual-trial-tech-to-janssen-in-multi-year-deal/
